These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 9215803)

  • 41. Human immunodeficiency virus type 1 induces lytic cycle replication of Kaposi's-sarcoma-associated herpesvirus: role of Ras/c-Raf/MEK1/2, PI3K/AKT, and NF-κB signaling pathways.
    Zhu X; Zhou F; Qin D; Zeng Y; Lv Z; Yao S; Lu C
    J Mol Biol; 2011 Jul; 410(5):1035-51. PubMed ID: 21763505
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Technical note on the isolation of HIV from peripheral lymphomonocytes: use of PHA].
    Fiore JR; Angarano G; Fico C; Fracasso C; Carbonara S; Pastore G
    Boll Soc Ital Biol Sper; 1990 May; 66(5):499-503. PubMed ID: 2397110
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Engineered CD4- and CXCR4-using simian immunodeficiency virus from African green monkeys is neutralization sensitive and replicates in nonstimulated lymphocytes.
    König RR; Flory E; Steidl S; Neumann J; Coulibaly C; Holznagel E; Holzammer S; Norley S; Cichutek K
    J Virol; 2002 Nov; 76(21):10627-36. PubMed ID: 12368305
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Oxyradical-mediated chromosome damage in patients with familial Mediterranean fever.
    Emerit I; Arutyunyan R; Sarkisian T; Mejlumian H; Torosian E; Panossian AG
    Free Radic Biol Med; 1993 Sep; 15(3):265-71. PubMed ID: 8406126
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Natural killer cells from human immunodeficiency virus (HIV)-infected individuals are an important source of CC-chemokines and suppress HIV-1 entry and replication in vitro.
    Oliva A; Kinter AL; Vaccarezza M; Rubbert A; Catanzaro A; Moir S; Monaco J; Ehler L; Mizell S; Jackson R; Li Y; Romano JW; Fauci AS
    J Clin Invest; 1998 Jul; 102(1):223-31. PubMed ID: 9649576
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inhibition of HIV type 1 replication by simultaneous infection of peripheral blood lymphocytes with human immunodeficiency virus types 1 and 2.
    Dern K; Rübsamen-Waigmann H; Unger RE
    AIDS Res Hum Retroviruses; 2001 Mar; 17(4):295-309. PubMed ID: 11242517
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Inhibition of human immunodeficiency virus type 1 replication in vitro in acutely and persistently infected human CD4+ mononuclear cells expressing murine and humanized anti-human immunodeficiency virus type 1 Tat single-chain variable fragment intrabodies.
    Mhashilkar AM; LaVecchio J; Eberhardt B; Porter-Brooks J; Boisot S; Dove JH; Pumphrey C; Li X; Weissmahr RN; Ring DB; Ramstedt U; Marasco WA
    Hum Gene Ther; 1999 Jun; 10(9):1453-67. PubMed ID: 10395371
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Correlation of viral replication activity, the clinical phase of the disease and immunologic deterioration in HIV infection].
    Fico C; Angarano G; Fiore JR; Casalino C; Salamina GF; Pastore G
    Boll Soc Ital Biol Sper; 1990 Feb; 66(2):189-93. PubMed ID: 1972627
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Host cell gene expression during human immunodeficiency virus type 1 latency and reactivation and effects of targeting genes that are differentially expressed in viral latency.
    Krishnan V; Zeichner SL
    J Virol; 2004 Sep; 78(17):9458-73. PubMed ID: 15308739
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Inhibition of human immunodeficiency virus type 1 replication by regulated expression of a polymeric Tat activation response RNA decoy as a strategy for gene therapy in AIDS.
    Lisziewicz J; Sun D; Smythe J; Lusso P; Lori F; Louie A; Markham P; Rossi J; Reitz M; Gallo RC
    Proc Natl Acad Sci U S A; 1993 Sep; 90(17):8000-4. PubMed ID: 8367455
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Reactive oxygen species, chromosome mutation, and cancer: possible role of clastogenic factors in carcinogenesis.
    Emerit I
    Free Radic Biol Med; 1994 Jan; 16(1):99-109. PubMed ID: 8300000
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cytokine network and HIV syncytium-inducing phenotype shift.
    Torres Y; Medrano FJ; Rey C; Calderón EJ; Sanchez-Quijano A; Lissen E; Leal M
    AIDS; 1996 Aug; 10(9):1053-5. PubMed ID: 8853748
    [No Abstract]   [Full Text] [Related]  

  • 53. Quantitation of human immunodeficiency virus in vertically infected infants and children.
    Alimenti A; Luzuriaga K; Stechenberg B; Sullivan JL
    J Pediatr; 1991 Aug; 119(2):225-9. PubMed ID: 1677684
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Human immunodeficiency virus (HIV) type 2-mediated inhibition of HIV type 1: a new approach to gene therapy of HIV-infection.
    Arya SK; Gallo RC
    Proc Natl Acad Sci U S A; 1996 Apr; 93(9):4486-91. PubMed ID: 8633095
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The enzymatic antioxidant system in blood and glutathione status in human immunodeficiency virus (HIV)-infected patients: effects of supplementation with selenium or beta-carotene.
    Delmas-Beauvieux MC; Peuchant E; Couchouron A; Constans J; Sergeant C; Simonoff M; Pellegrin JL; Leng B; Conri C; Clerc M
    Am J Clin Nutr; 1996 Jul; 64(1):101-7. PubMed ID: 8669404
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Interferon alpha in the treatment of AIDS-related Kaposi's sarcoma.
    Mitsuyasu RT
    Br J Haematol; 1991 Oct; 79 Suppl 1():69-73. PubMed ID: 1931714
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clastogenic factors as potential biomarkers of increased superoxide production.
    Emerit I
    Biomark Insights; 2007 Dec; 2():429-38. PubMed ID: 19662223
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Human immunodeficiency virus and acquired immunodeficiency syndrome: correlation but not causation.
    Duesberg PH
    Proc Natl Acad Sci U S A; 1989 Feb; 86(3):755-64. PubMed ID: 2644642
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Transforming growth factor beta suppresses human immunodeficiency virus expression and replication in infected cells of the monocyte/macrophage lineage.
    Poli G; Kinter AL; Justement JS; Bressler P; Kehrl JH; Fauci AS
    J Exp Med; 1991 Mar; 173(3):589-97. PubMed ID: 1705278
    [TBL] [Abstract][Full Text] [Related]  

  • 60. IL-10 inhibits HIV-1 replication and is induced by tat.
    Masood R; Lunardi-Iskandar Y; Moudgil T; Zhang Y; Law RE; Huang CL; Puri RK; Levine AM; Gill PS
    Biochem Biophys Res Commun; 1994 Jul; 202(1):374-83. PubMed ID: 8037735
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.